Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Clinical Investigation

• Publication date

  2000-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI8748PMID 10712434PMCID PMC292455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Usefulness of enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus

  1999cited by this paper
• The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.

  1999cited by this paper
• Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.

  1999cited by this paper
• Desmoglein 3 anchors telogen hair in the follicle.

  1998cited by this paper
• Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.

  1998cited by this paper
• Are there unique autoantigens triggering autoimmune diseases?

  1998cited by this paper
• Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.

  1997cited by this paper
• Targeted Disruption of the Pemphigus Vulgaris Antigen (Desmoglein 3) Gene in Mice Causes Loss of Keratinocyte Cell Adhesion with a Phenotype Similar to Pemphigus Vulgaris

  1997cited by this paper
• Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles.

  1997cited by this paper
• Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.

  1996cited by this paper
• Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

  1996cited by this paper
• Pemphigus: autoimmunity to epidermal cell adhesion molecules.

  1996cited by this paper
• Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients.

  1996cited by this paper
• Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus.

  1995cited by this paper
• Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus.

  1994cited by this paper
• Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins.

  1994cited by this paper
• Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients.

  1993cited by this paper
• Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion.

  1993cited by this paper
• Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic.

  1992cited by this paper
• Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion.

  1991cited by this paper
• Mechanisms of immunological tolerance.

  1989cited by this paper
• Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation

  1983cited by this paper
• Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease.

  1982cited by this paper
• A survey of transformation markers in differentiating epidermal cell lines in culture.

  1980cited by this paper
• Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum.

  1976cited by this paper

• 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response

  2026cites this paper
• Antigen-Fc fusion therapy reduces severity of a model of pemphigus vulgaris without systemic immunosuppression.

  2025cites this paper
• Pemphigoid disease model systems for clinical translation

  2025cites this paper
• Pemphigus: An Autoimmune Disease Model for Understanding the Role of Autoreactive T Cells.

  2025cites this paper
• Antigen-Specific Immune Responses and Microbiota Interactions in Skin: Insights into Autoimmune Skin Diseases and.

  2025cites this paper
• Conversion of pathogenic T cells into functionally stabilized Treg cells for antigen-specific immunosuppression in pemphigus vulgaris.

  2025cites this paper
• Generation of nanobodies from transgenic ‘LamaMice’ lacking an endogenous immunoglobulin repertoire

  2024cites this paper
• Immunostimulatory effects of Toll‐like receptor ligands as adjuvants in establishing a novel mouse model for pemphigus vulgaris

  2024influential citation
• The human skin organ culture model as an optimal complementary tool for murine pemphigus models

  2023cites this paper
• T Regulatory Cell-Associated Tolerance Induction by High-Dose Immunoglobulins in an HLA-Transgenic Mouse Model of Pemphigus

  2023cites this paper
• Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomised controlled trial.

  2023cites this paper
• Desmoglein-specific B-cell-targeted single-cell analysis revealing unique gene regulation in pemphigus patients.

  2023cites this paper
• A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants

  2023cites this paper
• Understanding CD4+ T cells in autoimmune bullous diseases

  2023cites this paper
• Engineered T cells and their therapeutic applications in autoimmune diseases

  2022cites this paper
• T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen

  2022cites this paper
• Autoimmune Pemphigus: Latest Advances and Emerging Therapies

  2022cites this paper
• In Vitro, Ex Vivo, and In Vivo Models for the Study of Pemphigus

  2022cites this paper
• Pitfalls in establishing mouse model of female infertility by immunization with human centromere protein.

  2021cites this paper
• Intravenous immunoglobulin regulates anti-desmoglein 3 IgG production in B220- antibody-producing cells in mice with pemphigus vulgaris.

  2021cites this paper
• Autoreactive T cells in pemphigus: perpetrator and target

  2021cites this paper
• The pathogeneses of pemphigus and pemphigoid diseases.

  2021cites this paper
• Critical appraisal of different triggering pathways for the pathobiology of pemphigus vulgaris-A review.

  2021cites this paper
• Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice

  2021influential citation
• Autoantibody-Specific Signalling in Pemphigus

  2021cites this paper
• Inhibition of immunoglobulin class-switching prevents pemphigus onset in desmoglein 3-specific B cell receptor knock-in mouse

  2021cites this paper
• Laser-induced cell injury in closed micro physiological systems: a novel method to study regeneration processes in vitro

  2020cites this paper
• Recent progresses and perspectives in autoimmune bullous diseases.

  2020cites this paper
• Clinical and biological activity of rituximab in the treatment of pemphigus.

  2020cites this paper
• Autoimmune bullous skin diseases, pemphigus and pemphigoid.

  2020cites this paper
• Antigen-specific B-cell depletion for precision therapy of mucosal pemphigus vulgaris.

  2020cites this paper
• Autoimmune Bullous Skin Diseases: Pemphigus and Pemphigoid

  2020cites this paper
• Autoantibodies to BPAG1e trigger experimental bullous pemphigoid in mice.

  2020cites this paper
• The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient

  2020cites this paper
• Pemphigus.

  2019cites this paper
• Autoimmune Bullous Diseases

  2019cites this paper
• Development of a Desmocollin-3 Active Mouse Model Recapitulating Human Atypical Pemphigus

  2019influential citation
• Radon Therapy for Autoimmune Diseases Pemphigus and Diabetes: 2 Case Reports

  2019cites this paper
• Autoimmunity and immunological tolerance in autoimmune bullous diseases.

  2019cites this paper
• Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses

  2019cites this paper
• Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune Disease

  2019cites this paper
• Implicación de ADAM10 en la acantólisis del pénfigo vulgar en un modelo murino

  2019cites this paper
• Alopecia in Autoimmune Blistering Diseases: A Systematic Review of Pathogenesis and Clinical Features of Disease

  2019cites this paper
• Plakophilin3 loss leads to an increase in lipocalin2 expression, which is required for tumour formation

  2018cites this paper
• Humoral Epitope Spreading in Autoimmune Bullous Diseases

  2018cites this paper
• A methodological review of induced animal models of autoimmune diseases.

  2018cites this paper
• Enhanced Response to Mouse Thyrotropin (TSH) Receptor Immunization in TSH Receptor Knockout Mice Short title: anti-mouse TSHR immune response in TSHR KO mice

  2018cites this paper
• Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus

  2018cites this paper
• A Life Full of Surprises and Excitement through Science in Dermatology.

  2018cites this paper
• Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches

  2018cites this paper
• The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the “Super Compensation Hypothesis”

  2018cites this paper
• Title Adoptive transfer of antithyrotropin receptor ( TSHR ) autoimmunity fromTSHR knockout mice to athymic nude mice

  2017cites this paper
• HLA-Disease Associations in Rheumatoid Arthritis

  2017cites this paper
• Research Techniques Made Simple: Mouse Models of Autoimmune Blistering Diseases.

  2017influential citation
• The possible role of interleukin-35 and its therapeutic potential in pemphigus.

  2017cites this paper
• A rare occurrence of epidermolysis bullosa acquisita in a patient with retroviral disease

  2017cites this paper
• A reciprocal HLA-Disease Association in Rheumatoid Arthritis and Pemphigus Vulgaris.

  2017cites this paper
• Pemphigus

  2017cites this paper
• Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis.

  2017cites this paper
• Characterization of cellular and humoral immune responses in pemphigus patients and an HLA-transgenic mouse model

  2016influential citation
• Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology

  2016cites this paper
• History and milestones of mouse models of autoimmune diseases.

  2015cites this paper
• The Immune System in Normal Skin and in AIBD

  2015cites this paper
• Immune cellular regulation on autoantibody production in pemphigus

  2015cites this paper
• Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses.

  2015cites this paper
• Immune response in pemphigus and beyond: progresses and emerging concepts

  2015cites this paper
• The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgaris

  2015cites this paper
• Autoimmune Bullous Skin Diseases-Pemphigus and Pemphigoid

  2014cites this paper
• Regulated by HLA-DRB 1 * 04 : 02 Desmoglein 3 in Pemphigus Vulgaris Are Pathogenic IgG Antibodies against

  2014cites this paper
• Pathogenic IgG Antibodies against Desmoglein 3 in Pemphigus Vulgaris Are Regulated by HLA-DRB1*04:02–Restricted T Cells

  2014cites this paper
• Molecular dermatology comes of age.

  2013cites this paper
• Autoimmunity Diseases of the Skin

  2013cites this paper
• Mechanistic Basis of Desmosome-Targeted Diseases

  2013cites this paper
• Pemphigus Vulgaris in Childhood Patient: A Case Report

  2013cites this paper
• Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida

  2013cites this paper
• Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris

  2013cites this paper
• An attempt to develop mouse model for anti-laminin γ1 pemphigoid.

  2013cites this paper
• Epidermolysis Bullosa CD4 Helper T Cell Response in Experimental Are Required To Induce an Autoreactive B Cells, Dendritic Cells, and Macrophages

  2013cites this paper
• Paraneoplastic Pemphigus Renders the Lung a Target Organ in Ectopic Expression of Epidermal Antigens

  2013cites this paper
• University of Birmingham Mechanistic basis of desmosome-targeted diseases

  2013cites this paper
• Bullous Skin Diseases: Classical Types of Autoimmune Diseases

  2013cites this paper
• Ectopic Expression of Epidermal Antigens Renders the Lung a Target Organ in Paraneoplastic Pemphigus

  2013cites this paper
• Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita

  2013cites this paper
• B Cells, Dendritic Cells, and Macrophages Are Required To Induce an Autoreactive CD4 Helper T Cell Response in Experimental Epidermolysis Bullosa Acquisita

  2013cites this paper
• Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris

  2013cites this paper
• Cell Clones Using Murine Pemphigus Pathogenicity of Desmoglein 3-Reactive T Novel System Evaluating In Vivo

  2013cites this paper
• p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity

  2013cites this paper
• BPIFB1 Is a Lung-Specific Autoantigen Associated with Interstitial Lung Disease

  2013cites this paper
• Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models

  2012cites this paper
• Autoimmunity against M2 muscarinic acetylcholine receptor induces myocarditis and leads to a dilated cardiomyopathy‐like phenotype

  2012cites this paper
• A young patient with persistent gingival bleeding.

  2012cites this paper
• Cytokine networks in Pemphigus vulgaris: An integrated viewpoint

  2012cites this paper
• Methods for revealing therapeutic targets in case of true acantholytic pemphigus

  2012cites this paper
• Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.

  2012cites this paper
• Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice.

  2012cites this paper
• Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.

  2012cites this paper
• Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease

  2012cites this paper
• Staphylococcus pseudintermedius exfoliative toxin EXI selectively digests canine desmoglein 1 and causes subcorneal clefts in canine epidermis.

  2011cites this paper
• Mechanobiology of Epidermal Keratinocytes: Desmosomes, Hemidesmosomes, Keratin Intermediate Filaments, and Blistering Skin Diseases

  2011cites this paper
• Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris.

  2011cites this paper